• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 498020 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416515340 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416515340 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Buyers Accumulate Shares of Ariad Pharmaceuticals, Up 1.7%

Published on Mon, 05/13/2013 - 10:29
By Mallory Stone

Ariad Pharmaceuticals (NASDAQ:ARIA), a company whose shares are moving quickly, is trading 1.7% higher to $16.60. The S&P is currently trading fractionally lower to 1,632 and the Dow Jones Industrial Average is trading fractionally lower to 15,091.

Ariad Pharmaceuticals (NASDAQ:ARIA) has potential upside of 69.8% based on a current price of $16.60 and analysts' consensus price target of $28.19. The stock should run into initial resistance at its 50-day moving average (MA) of $18.83 and subsequent resistance at its 200-day MA of $20.57.

ARIAD Pharmaceuticals, Inc. discovers and develops breakthrough medicines that regulate cell signaling with small molecules. The Company is primarily focused on product candidates for targeted indications. ARIAD is developing products to treat solid tumors, to block the spread of cancer, to treat certain forms of leukemia, and to treat cancer that has spread to bone and primary bone cancers.

In the past 52 weeks, shares of Ariad Pharmaceuticals have traded between a low of $15.13 and a high of $25.40 and are now at $16.60, which is 10% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 2.1%.

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Tesoro: The Winning Streak Continues (TS...

Tesoro (NYSE:TSO) traded at a new 52-week high today of $75.42. So far today approxima ...

Shares of Travelers Rise Above Previous ...

Shares of Travelers (NYSE:TRV) traded today at $103.72, breaking its 52-week high. App ...

TriQuint Semiconductor Looks to Continue...

TriQuint Semiconductor (NASDAQ:TQNT) traded today at a new 52-week high of $23.79. So ...

Shares of Tim Hortons Have Risen Above P...

Shares of Tim Hortons (NYSE:THI) traded today at $82.63, breaking its 52-week high. Th ...

Watch for Continued Gains in Shares of H...

Hanover Insurance (NYSE:THG) traded at a new 52-week high today of $70.35. This new hi ...

Shares of Taser International Rise to a ...

Shares of Taser International (NASDAQ:TASR) traded today at $20.93, breaking its 52-wee ...

Sunoco Logistics Partners Looks to Conti...

Sunoco Logistics Partners (NYSE:SXL) traded at a new 52-week high today of $51.75. So ...

Shares of Skyworks Solutions Rise Above ...

Skyworks Solutions (NASDAQ:SWKS) traded today at a new 52-week high of $64.91. Approxi ...